The lives of researcher, clinicians, and advocates are filled with conferences these days. Hundreds of confer-ences, meetings, and workshops focus on the topics of this journal, genetic testing and molecular biomarkers, alone. Even the topic of rare genetic diseases, formerly an under-served area, spawns dozens of meetings every year. Thus, in this morass, it is very rare that a meeting is significant enough to leave a lasting impression. My experience at the OME Precision Medicine Summit (University of California, San Francisco, 2013) stands out as extraordinary. University of California Chancellor Susan Desmond-Hellman convened about 150 people for this 2-day summit on May 1 and 2,2013. It was extraordinary in both the participants it engaged and the format. I left feeling sure that our time had not been wasted and that this was not the end of the fruit of our time together.
展开▼
